FR8105M - - Google Patents

Info

Publication number
FR8105M
FR8105M FR175388A FR175388A FR8105M FR 8105 M FR8105 M FR 8105M FR 175388 A FR175388 A FR 175388A FR 175388 A FR175388 A FR 175388A FR 8105 M FR8105 M FR 8105M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR175388A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR8105M publication Critical patent/FR8105M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
FR175388A 1967-09-04 1968-11-26 Expired FR8105M (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE1219667A SE324859B (no) 1967-09-04 1967-09-04

Publications (1)

Publication Number Publication Date
FR8105M true FR8105M (no) 1970-07-27

Family

ID=20295314

Family Applications (1)

Application Number Title Priority Date Filing Date
FR175388A Expired FR8105M (no) 1967-09-04 1968-11-26

Country Status (7)

Country Link
AT (1) AT280478B (no)
BE (1) BE720383A (no)
ES (1) ES358505A1 (no)
FR (1) FR8105M (no)
GB (1) GB1186990A (no)
NL (1) NL6812365A (no)
SE (1) SE324859B (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1120407A1 (en) * 1998-10-09 2001-08-01 Ajinomoto Co., Inc. Cysteine derivatives

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU174057B (hu) * 1976-09-17 1979-10-28 Richter Gedeon Vegyeszet Sostav dlja pokrytij obespechivajuhhij uregulirovannuju otdachy aktivnogo vehhestva biologicheski aktivnykh preparatov i sposob poluchenija takikh preparatov s uregulirovannoj otdachej aktivnogo vehhestva
EP0211991B1 (en) * 1982-07-08 1989-10-25 Ab Leo Substained release tablets and method for preparation thereof
GB8322007D0 (en) * 1983-08-16 1983-09-21 Wellcome Found Pharmaceutical delivery system
USRE33994E (en) * 1983-08-16 1992-07-14 Burroughs Wellcome Co. Pharmaceutical delivery system
EP0467488B1 (en) * 1984-08-17 1995-10-11 The Wellcome Foundation Limited Composition for the controlled discharge of an active ingredient
US5178868A (en) * 1988-10-26 1993-01-12 Kabi Pharmacia Aktiebolaq Dosage form

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1120407A1 (en) * 1998-10-09 2001-08-01 Ajinomoto Co., Inc. Cysteine derivatives
EP1120407B1 (en) * 1998-10-09 2013-02-20 Ajinomoto Co., Inc. Cystine derivatives

Also Published As

Publication number Publication date
ES358505A1 (es) 1970-04-16
GB1186990A (en) 1970-04-08
AT280478B (de) 1970-04-10
BE720383A (no) 1969-02-17
SE324859B (no) 1970-06-15
NL6812365A (no) 1969-03-06

Similar Documents

Publication Publication Date Title
AU425114B2 (no)
AT298283B (no)
FR8105M (no)
AU416737B2 (no)
AU2277767A (no)
AU342066A (no)
AU610966A (no)
AU3151267A (no)
AU2256867A (no)
AU2116667A (no)
AU2454867A (no)
AU3189468A (no)
AU2528767A (no)
AU2977667A (no)
BE426053A (no)
BE514578A (no)
AU25066A (no)
AU2406369A (no)
AU34866A (no)
AU408412B2 (no)
AU1868267A (no)
AU1763766A (no)
AU459699A (no)
AU1677166A (no)
AU1614766A (no)